IRadimed Corporation
IRMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $696,862 | $598,262 | $355,403 | $570,517 |
| - Cash | $52,234 | $49,762 | $57,961 | $62,000 |
| + Debt | $155 | $2,043 | $2,205 | $2,482 |
| Enterprise Value | $644,783 | $550,543 | $299,648 | $510,999 |
| Revenue | $73,242 | $65,562 | $53,303 | $41,815 |
| % Growth | 11.7% | 23% | 27.5% | – |
| Gross Profit | $56,350 | $50,158 | $41,282 | $32,050 |
| % Margin | 76.9% | 76.5% | 77.4% | 76.6% |
| EBITDA | $22,782 | $20,801 | $16,298 | $11,225 |
| % Margin | 31.1% | 31.7% | 30.6% | 26.8% |
| Net Income | $19,234 | $17,193 | $12,828 | $9,325 |
| % Margin | 26.3% | 26.2% | 24.1% | 22.3% |
| EPS Diluted | 1.5 | 1.35 | 1.02 | 0.74 |
| % Growth | 11.1% | 32.4% | 37.8% | – |
| Operating Cash Flow | $25,624 | $13,465 | $10,043 | $11,258 |
| Capital Expenditures | -$8,005 | -$8,007 | -$1,875 | -$742 |
| Free Cash Flow | $17,619 | $5,458 | $8,168 | $10,516 |